<html>
<head>PUBMED IDs for SLAMF3</head>
<body bgcolor='#C5F0F2'><h1>SLAMF3</h1><a href='https://pubmed.ncbi.nlm.nih.gov/20923684/'>Differential expression of SLAMS and other modulatory molecules by human plasma cells during normal maturation.</a> May 3  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20933013/'>Expression of SLAM (CD150) cell-surface receptors on human B-cell subsets: from pro-B to plasma cells.</a> May 3  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/22989874/'>CD3-T cell receptor co-stimulation through SLAMF3 and SLAMF6 receptors enhances RORÎ³t recruitment to the IL17A promoter in human T lymphocytes.</a> January 24  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/23064403/'>The chicken SLAM family.</a> February 23  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24376606/'>Identification of SLAMF3 (CD229) as an inhibitor of hepatocellular carcinoma cell proliferation and tumour progression.</a> October 7  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24376606/'>Identification of SLAMF3 (CD229) as an inhibitor of hepatocellular carcinoma cell proliferation and tumour progression.</a> October 7  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24927415/'>The expression of the hepatocyte SLAMF3 (CD229) receptor enhances the hepatitis C virus infection.</a> October 27  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/24957954/'>Neurocysticercosis: the effectiveness of the cysticidal treatment could be influenced by the host immunity.</a> July 17  2014<br></body></html>
